Regeneron Pharmaceuticals (REGN)

Total Costs & Expenses

$11.56B

TTM · Period ending: · USD

REGN logo

REGN Total Costs & Expenses

Latest reported$11.56B
REGN TTM Total Costs & Expenses (-$8.30M → $11.56B)
High-resolution chart · PNG

REGN total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
11,564,600,000
11,290,500,000
10,765,000,000
10,559,600,000
10,373,300,000
10,254,700,000
10,211,300,000
9,795,900,000
9,406,400,000
9,070,500,000
8,836,200,000
8,551,600,000
8,112,400,000
7,521,100,000
7,040,300,000
7,253,300,000
7,146,400,000
7,387,400,000
7,124,900,000
6,068,800,000
5,704,100,000
5,208,400,000
4,920,500,000
4,852,400,000
4,616,700,000
4,583,300,000
4,347,800,000
4,369,700,000
4,401,073,000
4,124,707,000
4,176,361,000
4,010,297,000
3,914,471,000
3,848,441,000
3,792,636,000
3,628,824,000
3,545,397,000
3,546,594,000
3,529,686,000
3,516,857,000
3,404,537,000
3,137,294,000
2,851,812,000
2,539,779,000
2,337,848,000
2,127,384,000
1,981,126,000
1,824,503,000
1,641,659,000
1,497,904,000
1,344,717,000
1,215,310,000
1,080,408,000
997,790,000
920,764,000
820,211,000
756,178,000
707,386,000
650,983,000
629,056,000
605,839,000
577,320,000
556,328,000
546,084,000
526,757,000
493,445,000
455,464,000
409,692,000
376,461,000
350,205,000
328,287,000
314,115,000
289,578,000
262,335,000
239,478,000
207,046,000
189,949,000
180,657,000
171,102,000
-74,621,000
-67,921,000
-62,895,000
-58,228,000
186,779,000
182,196,000
174,724,000
168,371,000
163,666,000
160,763,000
157,166,000
157,485,000
158,620,000
154,267,000
152,322,000
143,941,000
138,389,000
128,421,000
116,766,000
107,656,000
102,588,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.